Showing results (1051-1060 of 1,341) with videos related to
Sort By:
Pageof 135
Cardiovascular Journal of Africa|January 3, 2023
Feasibility of focused cardiac ultrasound training for non-cardiologists in a resource-limited setting using a handheld ultrasound machineBenjamin Acheampong, Joseph R Starnes, Yaw A Awuku, et al.Cardiovascular Journal of Africa|May 13, 2015
Familial clustering of risk factors for cardiovascular disease among first-degree relatives of patients with chronic kidney disease in a sub-Saharan African populationYemi Raji, Omolara Mabayoje, Taslim BelloCardiovascular Journal of Africa|May 13, 2015
Stroke genomics in people of African ancestry: charting new pathsR O Akinyemi, B Ovbiagele, A Akpalu, et al.Cardiovascular Journal of Africa|May 13, 2015
Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patientsAmbroise Wonkam, Julie Makani, Solomon Ofori-Aquah, et al.Cardiovascular Journal of Africa|May 13, 2015
Endothelial dysfunction: a unifying hypothesis for the burden of cardiovascular diseases in sub-Saharan AfricaUchechukwu K A Sampson, Michael M Engelgau, Emmanuel K Peprah, et al.Cardiovascular Journal of Africa|December 17, 2010
Global cardiovascular risk profiles of untreated hypertensives in an urban, developing community in AfricaM J Maseko, G R Norton, O H Majane, et al.Cardiovascular Journal of Africa|January 26, 2011
Cardiogenic shock due to dynamic left ventricular outflow tract obstruction of acute myocardial infarction: an under-diagnosed complicationC Y Karabay, G Kocabay, A Kalayci, et al.Cardiovascular Journal of Africa|June 10, 2010
Factors associated with mortality when chronic betablocker therapy is withdrawn in the peri-operative period in vascular surgical patients: a matched case-control studyB M BiccardCardiovascular Journal of Africa|June 10, 2010
Comparison of ivabradine plus beta-blockers versus beta -blocker therapy onlyJ AalbersCardiovascular Journal of Africa|June 10, 2010
ACCORD LIPID study results strengthen guideline approach of adding fenofibrate to therapy of dyslipidaemic type 2 diabetic patientsJ AalbersPageof 135